Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alumis Inc. - Common Stock (NQ:ALMS)

23.66 -0.10 (-0.42%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	977,299
Open	23.95
Bid (Size)	23.64 (400)
Ask (Size)	24.21 (100)
Prev. Close	23.76
Today's Range	23.44 - 24.36
52wk Range	2.760 - 30.60
Shares Outstanding	53,752,223
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗

February 03, 2026

This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.

Via The Motley Fool

An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million ↗

January 17, 2026

Biotech innovator Alumis, focused on autoimmune therapies, reported a significant insider buy amid a year of robust stock gains.

Via The Motley Fool

Performance

YTD	+164.2%	+164.2%
1 Month	+4.2%	+4.2%
3 Month	-9.7%	-9.7%
6 Month	+401.3%	+401.3%
1 Year	+344.7%	+344.7%

More News

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

January 08, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗

January 08, 2026

Via Stocktwits

Unusual volume stocks in Wednesday's session ↗

January 07, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗

January 07, 2026

Via Stocktwits

Dow Clears 49,000 as AI’s “Data Deluge” Ignites a Memory-Stock Melt-Up ↗

January 07, 2026

Via Chartmill

Alumis Stock Hits Record High As Wall Street Cheers Phase 3 Psoriasis ‘Win’ — Analysts See Best-In-Class Potential ↗

January 06, 2026

Via Stocktwits

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗

January 06, 2026

Via The Motley Fool

The Great Rotation: Small-Caps Lead 2026 Market Charge as Tech Giants Stumble

January 06, 2026

Via MarketMinute

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why

January 06, 2026

Via AB Newswire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 06, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Why Is ALMS Stock Rising Today? ↗

January 06, 2026

Via Stocktwits

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 06, 2026

Via Chartmill

Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program

January 06, 2026

From Alumis Inc.

Via GlobeNewswire

Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗

January 06, 2026

Via Stocktwits

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗

December 29, 2025

Via The Motley Fool

What's going on in today's session ↗

December 05, 2025

Via Chartmill

Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗

December 05, 2025

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Via Chartmill

Amer Sports Posts Upbeat Q3 Earnings, Joins Diginex, James Hardie Industries And Other Big Stocks Moving Higher On Tuesday ↗

November 18, 2025

Via Benzinga

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 20, 2025

Via Benzinga

Alumis Misses Q2 Revenue as Costs Jump ↗

August 13, 2025

Via The Motley Fool

Frequently Asked Questions

Is Alumis Inc. - Common Stock publicly traded?

Yes, Alumis Inc. - Common Stock is publicly traded.

What exchange does Alumis Inc. - Common Stock trade on?

Alumis Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Alumis Inc. - Common Stock?

The ticker symbol for Alumis Inc. - Common Stock is ALMS on the Nasdaq Stock Market

What is the current price of Alumis Inc. - Common Stock?

The current price of Alumis Inc. - Common Stock is 23.66

When was Alumis Inc. - Common Stock last traded?

The last trade of Alumis Inc. - Common Stock was at 05/08/26 04:00 PM ET

What is the market capitalization of Alumis Inc. - Common Stock?

The market capitalization of Alumis Inc. - Common Stock is 1.27B

How many shares of Alumis Inc. - Common Stock are outstanding?

Alumis Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.